Skip to search.
 FTSE 100 Up 0.70%

AbbVie Inc. (ABBV)

-NYSE
61.22 Up 0.52(0.86%) 25 May 21:00
|After Hours: : 61.22 0.00 (0.00%) 22:37
Prev Close:60.70
Open:61.08
Bid:60.90 x 200
Ask:61.49 x 200
1y Target Est:71.06
Beta:1.42761
Earnings Date:22 Jul - 26 Jul (Est.)
Day's Range:60.79 - 61.47
52wk Range:45.45 - 71.60
Volume:5,857,619
Avg Vol (3m):7,650,090
Market Cap:99.03b
P/E (ttm):18.41
EPS (ttm):3.33
Div & Yield:2.28 (3.84%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.86%99.03b
PFEUp 0.73%208.33b
MRKUp 1.74%156.59b

Key Statistics

Forward P/E (1 yr):10.85
P/S (ttm):4.13
Ex-Dividend Date:13-Apr-16

Analysts

Annual EPS Est (Dec-16) :4.76
Quarterly EPS Est (Jun-16) :1.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):0.78

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback